Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to cyclopentano-hydrophenanthrene ; derivative thereof
Patent
1992-05-11
1994-02-15
Lacey, David L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to cyclopentano-hydrophenanthrene ; derivative thereof
5303891, 5303911, 5303915, 5303871, 424 153, 424 169, A61K 3514, C07K 300
Patent
active
052868508
ABSTRACT:
The subject matter of the present invention relates to bifunctional cyclohexyl DPTA ligands and methods for utilizing these compounds. Antibody DTPA-type ligand conjugates are also provided.
REFERENCES:
patent: 4339426 (1982-07-01), Meares et al.
patent: 4824986 (1989-04-01), Gansow
patent: 4881175 (1989-11-01), Ladner
Waldmann et al, Science, 252:1657-62, 1991 Monoclonal . . . Therapy.
Brechbiel et al., "Synthesis of 1-(p-Isothiocyanatobenzyl) Derivatives of DTPA and EDTA, Antibody Labeling and Tumor-Imaging Studies," Inorganic Chemistry, 2772-2781, Jul. 30, 1986.
Gansow et al., "Generator-Produced Bi-212 Chelated to Chemically Modified Monoclonal Antibody for Use in Radiotherapy," ACS Symposium Series 241, Radionuclide Generators, 215-227, American Chemical Society, Washington, D.C. 1984.
Hnatowich et al., "DTPA-Coupled Antibodies Labeled with Yttrium-90," J. Nucl. Med., 26(5): 503-509, May 1985.
Hnatowich et al., "The Preparation and Labeling of DTPA-Coupled Albumin," Int. J. Appl. Radiat. Isot., 33: 327-332, 1982.
Khaw et al., "Myocardial Infarct Imaging of Antibodies to Canine Cardiac Myosin with Indium-111-Diethylenetriamine Pentaacetic Acid," Science, 209: 295-297, Jul. 1980.
Kozak et al., "Bismuth-212-labeled anti-Tac monoclonal antibody: .alpha.-Particle-emitting radionuclides as modalities for radioimmunotherapy," Proc. Natl. Acad. Sci. USA, 83: 474-478, Jan. 1986.
Kozak et al., "Nature of the Bifunctional Chelating Agent Used for Radioimmunotherapy with Yttrium-90 Monoclonal Antibodies: Critical Factors in Determining in Vivo Survival and Organ Toxicity," Cancer Research, 49: 2639-2644, May 15, 1989.
Kozak et al., "Radionuclide-conjugated monoclonal antibodies: a synthesis of immunology, inorganic chemistry and nuclear science," Tibtech, 259-263, Oct. 1986.
Krejcarek et al., "Covalent Attachment of Chelating Groups to Macromolecules," Biochemical and Biophysical Research Communications, 77(2): 581-585, 1977.
Macklis et al., "Radioimmunotherapy with Alpha-Particle-Emitting Immunoconjugates," Science, 240: 1024-1026, 1988.
Magerstadt et al., "Gd(DOTA): An Alternative to Gd(DTPA) as a T.sub.1,2 Relaxation Agent for NMR Imaging or Spectroscopy," Magnetic Resonance in Medicine, 3: 808-812, 1986.
Meares et al., "Conjugation of Antibodies with Bifunctional Chelating Agents: Isothiocyanate and Bromoacetamide Reagents, Methods of Analysis, and Subsequent Addition of Metal Ions," Analytical Biochemistry, 142: 68-78, 1984.
Morrison, "Genetically Engineered (Chimeric) Antibodies," Hospital Practice, 65-80, Oct. 15, 1989.
Paik et al., "Reduction of Background Activities by Introduction of a Diester Linkage Between Antibody and a Chelate in Radioimmunodetection of Tumor," J. Nucl. Med., 30(10): 1693-1701, Oct. 1989.
Rainsbury et al., "Tumour Localisation With Monoclonal Antibody Radioactively Labelled With Metal Chelate Rather Than Iodine," The Lancet, 1347-1348, Dec. 11, 1982.
Scheinberg et al., "Tumor Imaging with Radioactive Metal Chelates Conjugated to Monoclonal Antibodies," Science, 215: 1511-1513, Mar. 19, 1982.
Spirlet et al., "Structural Characterization of a Terbium(III) Complex with 1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic Acid, Lanthanide Ions and the Conformation of the 14-Membered Macrocycles," Inorg. Chem., 23: 4278-4283, 1984.
Brechbiel Martin W.
Gansoh Otto A.
Eisenschenk F. C.
Lacey David L.
The United States of America as represented by the Department of
LandOfFree
Antibody DTPA-type ligand conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody DTPA-type ligand conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody DTPA-type ligand conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1208322